Data / Research funding / Washington / Institute for Systems Biology
Institute for Systems Biology: 33 NIH awards ($64.9M) and 4 NSF awards ($3.7M), fiscal years 2021 to 2026
Institute for Systems Biology in Seattle, WA is funded under 33 NIH awards ($64.9M) and 4 NSF awards ($3.7M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- SMK9PCMKXED6
- State
- Washington
Awards
37 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics) | NIH | National Cancer Institute | 2022 to 2025 | $10,596,037 | September 22, 2022 | August 31, 2027 | HEATH, JAMES R. | reporter.nih.gov |
| A systems analysis of drug tolerance in Mycobacterium tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,414,678 | December 1, 2016 | June 30, 2027 | BALIGA, NITIN S | reporter.nih.gov |
| Elucidating the role of TSR glycosylation in Plasmodium parasites | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,339,688 | June 1, 2020 | May 31, 2026 | SWEARINGEN, KRISTIAN EDWARD | reporter.nih.gov |
| CyberGut: towards personalized human-microbiome metabolic modeling for precision health and nutrition | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,006,256 | July 1, 2022 | April 30, 2027 | GIBBONS, SEAN MICHAEL | reporter.nih.gov |
| Systems biology of intratumoral heterogeneity in glioblastoma | NIH | National Cancer Institute | 2022 to 2025 | $2,962,426 | January 1, 2022 | December 31, 2026 | BALIGA, NITIN S | reporter.nih.gov |
| Dfam: sustainable growth, curation support, and improved quality for mobile element annotation | NIH | National Human Genome Research Institute | 2021 to 2025 | $2,827,494 | August 15, 2018 | June 30, 2028 | HUBLEY, ROBERT MACDONALD | reporter.nih.gov |
| A systems approach to manipulate microbial adaptation to structured environments | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,756,214 | June 7, 2019 | May 31, 2025 | BALIGA, NITIN S | reporter.nih.gov |
| Nano and biomolecular engineered technologies for neoantigen-specific T cell capture and characterization | NIH | National Cancer Institute | 2021 to 2025 | $2,704,913 | September 16, 2021 | June 30, 2027 | HEATH, JAMES R. | reporter.nih.gov |
| Transcriptional Control During Erythropoiesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,660,464 | September 16, 2013 | October 31, 2025 | RANISH, JEFFREY A | reporter.nih.gov |
| Host innate immune mechanisms control temporal expression of flagellin by pathogenic Salmonella | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,573,727 | June 10, 2021 | August 31, 2026 | SUBRAMANIAN, NAEHA | reporter.nih.gov |
| DOCKET: accelerating knowledge extraction from biomedical data sets | NIH | National Center for Advancing Translational Sciences | 2021 to 2024 | $2,504,189 | January 24, 2020 | November 30, 2024 | GLUSMAN, GWÊNLYN | reporter.nih.gov |
| Instability of Cancer Cell States in Tumor progression (ICCS) | NIH | National Cancer Institute | 2021 to 2025 | $2,456,986 | September 21, 2021 | August 31, 2027 | HUANG, SUI | reporter.nih.gov |
| NLRP3 inflammasome activation and its crosstalk with RLR signaling at the mitochondria | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,312,500 | June 15, 2021 | August 31, 2026 | SUBRAMANIAN, NAEHA | reporter.nih.gov |
| Development and Maintenance of RepeatMasker and RepeatModeler | NIH | National Human Genome Research Institute | 2022 to 2025 | $2,288,176 | February 4, 2022 | January 31, 2027 | SMIT, ARIAN FREDERICUS ANTHONIUS | reporter.nih.gov |
| Prototype System for AML Digital Twins | NIH | National Cancer Institute | 2023 to 2025 | $2,099,159 | January 1, 2023 | December 31, 2027 | THORSSON, VESTEINN | reporter.nih.gov |
| EVIDARA: Automated Evidential Support from Raw Data for relay agents in Biomedical KG Queries | NIH | National Center for Advancing Translational Sciences | 2021 to 2024 | $2,047,065 | January 24, 2020 | February 28, 2025 | HUANG, SUI | reporter.nih.gov |
| Defining the immunogenic landscape of early mosquito-stage P. falciparum to accelerate malaria transmission-blocking vaccine discovery | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,917,896 | July 5, 2024 | May 31, 2029 | SWEARINGEN, KRISTIAN EDWARD | reporter.nih.gov |
| Single-cell transcriptomics of complex bacterial communities | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,595,871 | July 8, 2023 | June 30, 2028 | KUCHINA, ANNA | reporter.nih.gov |
| How does spatial differentiation of ecotypes enhance microbial mutualism? | NSF | Organismal Interactions & Ecology | 2026 | $1,585,262 | September 1, 2026 | August 31, 2029 | Nitin Baliga | nsf.gov |
| The Expedit-Isotopomeric CrossLinking Mass Spectrometry (Expedit-ICLMS) technology for mapping global and dynamic protein-protein interaction networks | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,505,839 | April 1, 2020 | March 31, 2025 | RANISH, JEFFREY A | reporter.nih.gov |
| Liquid biopsy-based toolkits for neoantigen and cognate TCR discovery for cancer immunotherapy | NIH | National Cancer Institute | 2021 to 2023 | $1,338,731 | September 5, 2021 | August 31, 2025 | WEI, WEI | reporter.nih.gov |
| Capacity: BBSRC-NSF/BIO: Globally harmonized re-analysis of Data Independent Acquisition (DIA) proteomics datasets enables the creation of new resources (DIA-eXchange) | NSF | Infrastructure, Institutes, & Centers | 2023 | $1,200,698 | September 1, 2023 | March 31, 2027 | Eric Deutsch | nsf.gov |
| Development of a Predictive Frailty Clock & Longitudinal Investigation of its Epigenetic Determinants | NIH | National Institute on Aging | 2023 to 2025 | $1,022,727 | September 1, 2021 | May 31, 2026 | KANE, ALICE E | reporter.nih.gov |
| Theory and Measurement of Cell Population Dynamics with Cell-Cell Interaction (TMCC) | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $839,790 | September 20, 2019 | June 30, 2024 | HUANG, SUI | reporter.nih.gov |
| Steady states and cellular transitions associated with carcinogenesis and tumorprogression | NIH | National Cancer Institute | 2021 | $670,711 | August 8, 2017 | July 31, 2023 | HEATH, JAMES R. | reporter.nih.gov |
| Shortening the development cycle time of Trans Proteomic Pipeline tools with high performance computing | NIH | National Institute of General Medical Sciences | 2021 | $624,789 | September 1, 2010 | April 30, 2023 | DEUTSCH, ERIC | reporter.nih.gov |
| RarecyteFinder: A Bench-to-Bits Toolkit for Label-Free, Whole-Spectrum Analysis of Rare Disseminated Tumor Cells in Liquid and Tissue Biopsies | NIH | National Cancer Institute | 2025 | $554,653 | January 1, 2025 | December 31, 2028 | WEI, WEI | reporter.nih.gov |
| Enhancing insight into placental dysfunction in common obstetric disorders using placental multiomics | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $540,641 | July 11, 2024 | June 30, 2027 | HADLOCK, JENNIFER | reporter.nih.gov |
| Does post-transcriptional control of NLRP3 inflammasome activity impact development of type 1 diabetes? | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $539,428 | May 12, 2021 | April 30, 2024 | SUBRAMANIAN, NAEHA | reporter.nih.gov |
| A non-canonical role of Caspase-1 in regulating bacterial antimicrobial resistance | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $517,000 | September 1, 2024 | November 30, 2026 | AKHADE, AJAY SURESH | reporter.nih.gov |
| Strategies for discerning chemotherapy response and resistance in ovarian cancer | NIH | National Cancer Institute | 2022 | $510,364 | September 15, 2022 | August 31, 2025 | WEI, WEI | reporter.nih.gov |
| PRODIGE: A high-throughput tool for joint profiling of protein-DNA interactions and gene expression in single cells | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $503,250 | September 30, 2021 | August 31, 2024 | WEI, WEI | reporter.nih.gov |
| RCN-UBE: Networking Next Gen Biologists with Community College Educators | NSF | Infrastructure, Institutes, & Centers | 2022 | $499,719 | September 1, 2022 | August 31, 2027 | Jennifer Eklund | nsf.gov |
| REU Site: Research Opportunities in Systems Biology | NSF | Division of Biological Infrastructure | 2022 | $404,009 | April 1, 2022 | September 30, 2025 | Jennifer Eklund | nsf.gov |
| Enhancing personalized insights into common obstetric disorders using longitudinal deep-phenotyping data | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2024 | $285,660 | August 10, 2023 | July 31, 2025 | PIEKOS, SAMANTHA | reporter.nih.gov |
| Modeling the dynamics and composition of T-cell receptor repertoires in post-acute sequelae of COVID-19 (PASC) | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $194,942 | December 18, 2023 | October 31, 2025 | HADLOCK, JENNIFER | reporter.nih.gov |
| A systems approach to understanding overall drug response in a heterogeneous tumor-cell population | NIH | National Cancer Institute | 2021 to 2022 | $144,400 | February 3, 2020 | February 2, 2023 | PARK, JAMES HYUN-WOO | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2026 | 0 | $0 | 1 | $1,585,262 |
| 2025 | 18 | $11,530,652 | 0 | $0 |
| 2024 | 22 | $13,932,816 | 1 | $411,282 |
| 2023 | 21 | $14,694,425 | 1 | $789,416 |
| 2022 | 22 | $14,161,059 | 2 | $903,728 |
| 2021 | 19 | $10,537,712 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 9 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 9 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 9 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 9 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 9 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 9 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) | PA-24-187 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
Topics of its NIH awards
- Genetics
- Bioengineering
- Cancer
- Biotechnology
- Human Genome
- Infectious Diseases
- Rare Diseases
- Emerging Infectious Diseases
- Orphan Drug
- Precision Medicine
- Biodefense and Related Countermeasures
- Cancer Genomics
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.